InsiderTrades.com logo

JAZZ Insider Trading

Insider Ownership Percentage: 4.30%
Insider Buying (Last 12 Months): $9,992,963.00
Insider Selling (Last 12 Months): $37,018,170.71

Jazz Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Jazz Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Jazz Pharmaceuticals Share Price & Price History

Current Price: $180.62
Price Change: ▼ Price Decrease of -1.18 (-0.65%)
As of 03/20/2026 05:00 PM ET

This chart shows the closing price history over time for JAZZ up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Jazz Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/9/2026Patricia CarrCAOSell1,287$182.94$235,443.786,512View SEC Filing Icon  
2/27/2026Norbert G. RiedelDirectorSell3,415$192.00$655,680.007,024View SEC Filing Icon  
2/27/2026Patricia CarrCAOSell1,117$190.91$213,246.479,235View SEC Filing Icon  
2/26/2026Mary Elizabeth HendersonSVPSell5,343$194.49$1,039,160.0728,728View SEC Filing Icon  
2/26/2026Neena M. PatilEVPSell55,600$191.56$10,650,736.0056,862View SEC Filing Icon  
2/26/2026Patricia CarrCAOSell1,253$194.11$243,219.8310,352View SEC Filing Icon  
12/9/2025Mary Elizabeth HendersonSVPSell2,238$169.51$379,363.3819,508View SEC Filing Icon  
12/5/2025Patricia CarrCAOSell4,660$171.20$797,792.007,012View SEC Filing Icon  
11/26/2025Bruce C. CozaddDirectorSell77,500$177.81$13,780,275.00393,332View SEC Filing Icon  
11/20/2025Heather Ann McSharryDirectorSell3,415$177.78$607,118.7020,449View SEC Filing Icon  
11/18/2025Bruce C. CozaddDirectorSell18,000$181.09$3,259,620.00390,826View SEC Filing Icon  
11/18/2025Patricia CarrCAOSell5,319$182.06$968,377.147,012View SEC Filing Icon  
11/18/2025Rick E. WinninghamDirectorSell5,500$180.86$994,730.008,893View SEC Filing Icon  
11/17/2025Robert IannoneEVPSell7,159$168.26$1,204,573.3472,628View SEC Filing Icon  
10/3/2025Bruce C. CozaddDirectorSell3,500$140.00$490,000.00408,826View SEC Filing Icon  
10/1/2025Bruce C. CozaddDirectorSell2,000$131.78$263,560.00412,326View SEC Filing Icon  
9/2/2025Bruce C. CozaddDirectorSell6,000$128.62$771,720.00429,973View SEC Filing Icon  
7/1/2025Bruce C. CozaddCEOSell1,000$107.63$107,630.00436,973View SEC Filing Icon  
6/2/2025Bruce C. CozaddCEOSell500$107.90$53,950.00438,473View SEC Filing Icon  
5/12/2025Seamus MulliganDirectorBuy1,621$103.00$166,963.00101,621View SEC Filing Icon  
5/9/2025Seamus MulliganDirectorBuy100,000$98.26$9,826,000.00100,000View SEC Filing Icon  
5/1/2025Bruce C. CozaddCEOSell1,000$116.35$116,350.00439,307View SEC Filing Icon  
4/1/2025Bruce C. CozaddCEOSell1,500$123.75$185,625.00440,307View SEC Filing Icon  
3/10/2025Patricia CarrCAOSell1,140$137.81$157,103.407,012View SEC Filing Icon  
3/10/2025Robert IannoneCMOSell2,403$138.41$332,599.2379,621View SEC Filing Icon  
3/7/2025Robert IannoneCMOSell7,080$138.60$981,288.0082,024View SEC Filing Icon  
3/3/2025Bruce C. CozaddCEOSell6,500$144.25$937,625.00464,058View SEC Filing Icon  
2/27/2025Neena M. PatilEVPSell3,800$144.87$550,506.0033,318View SEC Filing Icon  
2/27/2025Patricia CarrCAOSell4,813$144.42$695,093.468,237View SEC Filing Icon  
2/3/2025Bruce C. CozaddCEOSell1,500$122.31$183,465.00439,744View SEC Filing Icon  
1/2/2025Bruce C. CozaddCEOSell1,500$123.43$185,145.00425,525View SEC Filing Icon  
12/2/2024Bruce C. CozaddCEOSell2,000$121.17$242,340.00427,025View SEC Filing Icon  
12/2/2024Patricia CarrCAOSell53$122.49$6,491.976,596View SEC Filing Icon  
11/8/2024Neena M. PatilEVPSell3,700$123.41$456,617.0033,048View SEC Filing Icon  
11/1/2024Bruce C. CozaddCEOSell1,000$110.84$110,840.00428,976View SEC Filing Icon  
9/6/2024Mary Elizabeth HendersonSVPSell1,410$108.30$152,703.0014,531View SEC Filing Icon  
6/7/2024Patricia CarrCAOSell163$108.83$17,739.296,596View SEC Filing Icon  
5/3/2024Neena M. PatilEVPSell5,000$109.65$548,250.0036,629View SEC Filing Icon  
3/6/2024Patricia CarrCAOSell1,936$119.64$231,623.048,364View SEC Filing Icon  
3/1/2024Philip L. JohnsonCFOBuy12,000$119.65$1,435,800.0027,932View SEC Filing Icon  
12/4/2023Mark Douglas SmithDirectorSell417$119.27$49,735.596,888View SEC Filing Icon  
9/1/2023Neena M. PatilEVPSell1,500$144.25$216,375.0029,186View SEC Filing Icon  
8/29/2023Patricia CarrCAOSell142$143.47$20,372.745,986View SEC Filing Icon  
8/15/2023Neena M. PatilEVPSell750$139.59$104,692.5030,686View SEC Filing Icon  
8/14/2023Patricia CarrCAOSell158$138.16$21,829.286,128View SEC Filing Icon  
8/14/2023Rick E. WinninghamDirectorSell1,241$138.16$171,456.5610,444View SEC Filing Icon  
6/7/2023Patricia CarrCAOSell126$127.92$16,117.926,286View SEC Filing Icon  
6/1/2023Neena M. PatilEVPSell1,600$127.98$204,768.0032,826View SEC Filing Icon  
5/18/2023Renée D. GaláCFOSell6,000$131.75$790,500.0035,978View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Jazz Pharmaceuticals (NASDAQ:JAZZ)

89.14% of Jazz Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at JAZZ by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Jazz Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/20/2026Hsbc Holdings PLC5,035$0.86M0.0%N/A0.008%Search for SEC Filing on Google Icon
3/17/2026Rockefeller Capital Management L.P.265,056$45.06M0.1%-4.3%0.431%Search for SEC Filing on Google Icon
3/9/2026Corient Private Wealth LLC10,200$1.73M0.0%+91.1%0.017%Search for SEC Filing on Google Icon
3/9/2026EMC Capital Management2,751$0.47M0.2%-15.0%0.004%Search for SEC Filing on Google Icon
2/24/2026DGS Capital Management LLC1,531$0.26M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/24/2026Pacer Advisors Inc.647,084$110M0.2%+19.8%1.065%Search for SEC Filing on Google Icon
2/23/2026Kera Capital Partners Inc.2,044$0.34M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/20/2026Dean Capital Management21,158$3.60M1.5%+3.2%0.035%Search for SEC Filing on Google Icon
2/19/2026Compound Planning Inc.1,841$0.31M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.191,296$32.52M0.0%+11.7%0.315%Search for SEC Filing on Google Icon
2/19/2026Corient Private Wealth LLC16,713$2.84M0.0%+213.2%0.028%Search for SEC Filing on Google Icon
2/18/2026Ameriflex Group Inc.549$93K0.0%+13,625.0%0.001%Search for SEC Filing on Google Icon
2/18/2026Mercer Global Advisors Inc. ADV6,947$1.18M0.0%+180.1%0.011%Search for SEC Filing on Google Icon
2/18/2026Vident Advisory LLC23,549$4M0.0%-5.7%0.039%Search for SEC Filing on Google Icon
2/18/2026First Citizens Bank & Trust Co.10,113$1.72M0.0%+3.6%0.017%Search for SEC Filing on Google Icon
2/18/2026State of Tennessee Department of Treasury29,581$4.87M0.0%-10.4%0.049%Search for SEC Filing on Google Icon
2/18/2026EP Wealth Advisors LLC5,689$0.97M0.0%N/A0.009%Search for SEC Filing on Google Icon
2/18/2026Mackenzie Financial Corp83,456$14.23M0.0%-59.8%0.137%Search for SEC Filing on Google Icon
2/18/2026Fuller & Thaler Asset Management Inc.1,677,132$285.11M1.0%+3.1%2.760%Search for SEC Filing on Google Icon
2/18/2026Empowered Funds LLC13,874$2.36M0.0%-7.3%0.023%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd6,494$1.10M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/18/2026Vestal Point Capital LP290,000$49.30M1.7%-42.0%0.477%Search for SEC Filing on Google Icon
2/18/2026SummitTX Capital L.P.126,795$21.56M0.6%+451.2%0.209%Search for SEC Filing on Google Icon
2/18/2026Susquehanna Portfolio Strategies LLC43,277$7.36M0.1%+0.8%0.071%Search for SEC Filing on Google Icon
2/18/2026Polymer Capital Management US LLC7,096$1.21M0.1%N/A0.012%Search for SEC Filing on Google Icon
2/18/2026Quadrature Capital Ltd5,588$0.95M0.0%N/A0.009%Search for SEC Filing on Google Icon
2/18/2026Occudo Quantitative Strategies LP12,128$2.06M0.1%+147.9%0.020%Search for SEC Filing on Google Icon
2/18/2026Odyssean LLC4,341$0.74M0.5%N/A0.007%Search for SEC Filing on Google Icon
2/18/2026Perceptive Advisors LLC170,000$28.90M0.5%N/A0.280%Search for SEC Filing on Google Icon
2/18/2026Man Group plc78,277$13.31M0.0%+81.3%0.129%Search for SEC Filing on Google Icon
2/18/2026Inspire Investing LLC7,650$1.30M0.1%N/A0.013%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC24,000$4.08M0.0%-5.1%0.039%Search for SEC Filing on Google Icon
2/18/2026Gotham Asset Management LLC61,200$10.40M0.0%+19.5%0.101%Search for SEC Filing on Google Icon
2/18/2026Engineers Gate Manager LP100,847$17.14M0.2%N/A0.166%Search for SEC Filing on Google Icon
2/18/2026Capitolis Liquid Global Markets LLC60,100$10.22M0.1%N/A0.098%Search for SEC Filing on Google Icon
2/18/2026Caption Management LLC10,747$1.83M0.0%-95.8%0.018%Search for SEC Filing on Google Icon
2/18/2026CastleKnight Management LP11,900$2.02M0.0%-19.0%0.020%Search for SEC Filing on Google Icon
2/18/2026Cinctive Capital Management LP6,339$1.08M0.1%N/A0.010%Search for SEC Filing on Google Icon
2/18/2026Clough Capital Partners L P12,517$2.13M0.2%N/A0.021%Search for SEC Filing on Google Icon
2/18/2026Balyasny Asset Management L.P.48,108$8.18M0.0%-88.9%0.079%Search for SEC Filing on Google Icon
2/18/2026Ardsley Advisory Partners LP50,000$8.50M0.9%N/A0.082%Search for SEC Filing on Google Icon
2/17/2026Guggenheim Capital LLC11,631$1.98M0.0%+11.0%0.019%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC8,000$1.36M0.1%+220.0%0.013%Search for SEC Filing on Google Icon
2/17/2026AQR Arbitrage LLC38,224$6.50M0.1%+14.7%0.063%Search for SEC Filing on Google Icon
2/17/2026Schonfeld Strategic Advisors LLC139,217$23.67M0.1%-68.1%0.229%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC877,267$149.14M0.1%+25.5%1.444%Search for SEC Filing on Google Icon
2/17/2026Cetera Investment Advisers6,076$1.03M0.0%-29.4%0.010%Search for SEC Filing on Google Icon
2/17/2026Lazard Asset Management LLC14,282$2.43M0.0%+4.7%0.024%Search for SEC Filing on Google Icon
2/17/2026Jain Global LLC35,375$6.01M0.0%+88.2%0.058%Search for SEC Filing on Google Icon
2/17/2026Estuary Capital Management LP106,387$18.09M3.2%-70.7%0.175%Search for SEC Filing on Google Icon
2/17/2026Kovack Advisors Inc.53,485$9.09M0.4%-1.4%0.088%Search for SEC Filing on Google Icon
2/17/2026Trexquant Investment LP7,287$1.24M0.0%N/A0.012%Search for SEC Filing on Google Icon
2/17/2026Amundi2,186$0.37M0.0%N/A0.004%Search for SEC Filing on Google Icon
2/17/2026Iron Triangle Partners LP292,170$49.67M5.7%+94.8%0.481%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD49,960$8.49M0.0%+7.0%0.082%Search for SEC Filing on Google Icon
2/17/2026Vinva Investment Management Ltd4,099$0.70M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/17/2026Rock Springs Capital Management LP1,750$0.30M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/17/2026Dean Investment Associates LLC40,947$6.96M1.0%+2.2%0.067%Search for SEC Filing on Google Icon
2/17/2026Osaic Holdings Inc.5,719$0.97M0.0%-59.6%0.009%Search for SEC Filing on Google Icon
2/17/2026Aristotle Capital Management LLC158,837$27M0.1%+0.5%0.261%Search for SEC Filing on Google Icon
2/17/2026Harvey Capital Management Inc.34,970$5.95M1.3%-7.4%0.058%Search for SEC Filing on Google Icon
2/17/2026Adage Capital Partners GP L.L.C.548,000$93.16M0.1%+258.2%0.902%Search for SEC Filing on Google Icon
2/17/2026Public Employees Retirement System of Ohio40,746$6.93M0.0%+112.8%0.067%Search for SEC Filing on Google Icon
2/17/2026Goldentree Asset Management LP420,341$71.34M3.9%-63.0%0.692%Search for SEC Filing on Google Icon
2/17/2026California State Teachers Retirement System52,171$8.87M0.0%-5.5%0.086%Search for SEC Filing on Google Icon
2/17/2026State of Wisconsin Investment Board34,512$5.87M0.0%-6.8%0.057%Search for SEC Filing on Google Icon
2/17/2026Captrust Financial Advisors5,001$0.85M0.0%+6.9%0.008%Search for SEC Filing on Google Icon
2/17/2026Fred Alger Management LLC1,806$0.31M0.0%-17.6%0.003%Search for SEC Filing on Google Icon
2/17/2026&PARTNERS2,633$0.45M0.0%-42.5%0.004%Search for SEC Filing on Google Icon
2/17/2026ExodusPoint Capital Management LP137,550$23.38M0.2%+554.8%0.226%Search for SEC Filing on Google Icon
2/17/2026Blair William & Co. IL1,746$0.30M0.0%-17.1%0.003%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada38,556$6.56M0.0%-78.5%0.063%Search for SEC Filing on Google Icon
2/17/2026Graham Capital Management L.P.1,214$0.21M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/17/2026Aster Capital Management DIFC Ltd177$30K0.0%-46.7%0.000%Search for SEC Filing on Google Icon
2/17/2026Faithward Advisors LLC29,274$4.98M0.7%+4.9%0.048%Search for SEC Filing on Google Icon
2/16/2026Sofinnova Investments Inc.959,860$163.18M6.6%+63.0%1.580%Search for SEC Filing on Google Icon
2/16/2026Towarzystwo Funduszy Inwestycyjnych PZU SA480$82K0.0%-57.0%0.001%Search for SEC Filing on Google Icon
2/16/2026Vanguard Personalized Indexing Management LLC5,481$0.93M0.0%+6.7%0.009%Search for SEC Filing on Google Icon
2/16/2026Verition Fund Management LLC40,590$6.90M0.0%+48.7%0.067%Search for SEC Filing on Google Icon
2/16/2026Panagora Asset Management Inc.93,802$15.95M0.1%+6,026.8%0.154%Search for SEC Filing on Google Icon
2/16/2026South Plains Financial Inc.386$66K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/16/2026MML Investors Services LLC2,648$0.45M0.0%-53.4%0.004%Search for SEC Filing on Google Icon
2/16/2026Mariner LLC25,341$4.31M0.0%+25.0%0.042%Search for SEC Filing on Google Icon
2/16/2026Focus Partners Wealth9,767$1.66M0.0%+115.0%0.016%Search for SEC Filing on Google Icon
2/16/2026Fieldview Capital Management LLC10,967$1.86M0.3%N/A0.018%Search for SEC Filing on Google Icon
2/16/2026GMT Capital Corp638,500$108.55M5.7%-19.5%1.051%Search for SEC Filing on Google Icon
2/16/2026Kennedy Capital Management LLC17,228$2.93M0.1%-1.1%0.028%Search for SEC Filing on Google Icon
2/16/2026DeepCurrents Investment Group LLC70,486$11.98M0.4%+0.2%0.116%Search for SEC Filing on Google Icon
2/16/2026Entropy Technologies LP28,463$4.84M0.3%N/A0.047%Search for SEC Filing on Google Icon
2/16/2026Arax Advisory Partners978$0.17M0.0%-30.5%0.002%Search for SEC Filing on Google Icon
2/16/2026Atlas Capital Advisors Inc.3,107$0.53M0.1%N/A0.005%Search for SEC Filing on Google Icon
2/13/2026Kestra Advisory Services LLC368$63K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/13/2026Fairbanks Capital Management Inc.23,419$3.98M2.2%-6.4%0.039%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP13,428$2.28M0.0%N/A0.022%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 547,743$93.12M0.1%+6.1%0.901%Search for SEC Filing on Google Icon
2/13/2026Johnson Investment Counsel Inc.17,494$2.97M0.0%-17.3%0.029%Search for SEC Filing on Google Icon
2/13/2026CANADA LIFE ASSURANCE Co35,574$6.05M0.0%+1.3%0.059%Search for SEC Filing on Google Icon
2/13/2026UMB Bank n.a.725$0.12M0.0%+12.6%0.001%Search for SEC Filing on Google Icon
2/13/2026Stifel Financial Corp122,749$20.87M0.0%-2.5%0.202%Search for SEC Filing on Google Icon
2/13/2026Hudson Bay Capital Management LP30,447$5.18M0.0%N/A0.050%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Jazz Pharmaceuticals logo
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products for unmet medical needs in the United States, Europe, and internationally. The company offers Xywav for cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia; Xyrem to treat cataplexy or EDS with narcolepsy; Epidiolex for seizures associated with Lennox-Gastaut and Dravet syndromes, or tuberous sclerosis complex; Zepzelca to treat metastatic small cell lung cancer, or with disease progression on or after platinum-based chemotherapy; Rylaze for acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Defitelio to treat severe hepatic veno-occlusive disease; and Vyxeos for newly-diagnosed therapy-related acute myeloid leukemia. It also develops Zanidatamab to treat HER2-expressing gastroesophageal adenocarcinoma (GEA), and patients with HER2-expressing metastatic GEA; Zepzelca for the treatment of patients with select relapsed/refractory solid tumors based on limited response in three solid tumor cohorts; JZP815, a pan-RAF kinase inhibitor that targets components of the mitogen-activated protein kinase; JZP898, a conditionally-activated interferon alpha molecule; Epidiolex to treat LGS, DS, and TSC; Suvecaltamide to treat parkinson's disease tremor; JZP150, a fatty acid amide hydrolase inhibitor program to treat post-traumatic stress disorder; and JZP441 to treat narcolepsy, IH, and other sleep disorders. The company has licensing and collaboration agreements with XL-protein GmbH to extend the plasma half-life of selected asparaginase product candidates; Redx Pharma plc for preclinical activities Ras/Raf/MAP kinase pathway program; and Autifony Therapeutics Limited on discovering and developing drug candidates targeting two different ion channel targets associated with neurological disorders. The company was incorporated in 2003 and is headquartered in Dublin, Ireland.
Read More on Jazz Pharmaceuticals

Today's Range

Now: $180.62
Low: $179.16
High: $184.00

50 Day Range

MA: $173.81
Low: $162.43
High: $196.83

52 Week Range

Now: $180.62
Low: $95.49
High: $198.00

Volume

1,076,783 shs

Average Volume

1,129,873 shs

Market Capitalization

$11.12 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.22

Who are the company insiders with the largest holdings of Jazz Pharmaceuticals?

Jazz Pharmaceuticals' top insider shareholders include:
  1. Bruce C Cozadd (CEO)
  2. Bruce C Cozadd (Director)
  3. Seamus Mulligan (Director)
  4. Robert Iannone (CMO)
  5. Robert Iannone (EVP)
  6. Neena M Patil (EVP)
  7. Mary Elizabeth Henderson (SVP)
  8. Heather Ann Mcsharry (Director)
  9. Patricia Carr (CAO)
  10. Rick E Winningham (Director)
  11. Norbert G Riedel (Director)
Learn More about top insider investors at Jazz Pharmaceuticals.

Who are the major institutional investors of Jazz Pharmaceuticals?

Jazz Pharmaceuticals' top institutional investors include:
  1. Vanguard Group Inc. — 9.74%
  2. Capital World Investors — 4.39%
  3. Dimensional Fund Advisors LP — 4.32%
  4. LSV Asset Management — 4.04%
  5. State Street Corp — 3.02%
  6. Franklin Resources Inc. — 2.99%
Learn More about top institutional investors of Jazz Pharmaceuticals stock.

Which major investors are selling Jazz Pharmaceuticals stock?

Within the previous quarter, JAZZ stock was sold by these institutional investors:
  1. JPMorgan Chase & Co.
  2. Goldentree Asset Management LP
  3. Perpetual Ltd
  4. Balyasny Asset Management L.P.
  5. Schonfeld Strategic Advisors LLC
  6. Estuary Capital Management LP
  7. Caption Management LLC
  8. Dimensional Fund Advisors LP
In the previous year, company insiders that have sold Jazz Pharmaceuticals company stock include:
  1. Bruce C Cozadd (CEO)
  2. Bruce C Cozadd (Director)
  3. Seamus Mulligan (Director)
  4. Robert Iannone (CMO)
  5. Robert Iannone (EVP)
  6. Neena M Patil (EVP)
  7. Mary Elizabeth Henderson (SVP)
  8. Heather Ann Mcsharry (Director)
  9. Patricia Carr (CAO)
Learn More investors selling Jazz Pharmaceuticals stock.

Which major investors are buying Jazz Pharmaceuticals stock?

During the last quarter, JAZZ stock was acquired by institutional investors including:
  1. Franklin Resources Inc.
  2. Bank of New York Mellon Corp
  3. Adage Capital Partners GP L.L.C.
  4. Sofinnova Investments Inc.
  5. Allianz Asset Management GmbH
  6. Zurcher Kantonalbank Zurich Cantonalbank
  7. AQR Capital Management LLC
  8. Perceptive Advisors LLC